Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors
NGM Biopharmaceuticals, Inc
NGM Biopharmaceuticals, Inc
Wellmarker Bio
Kineta Inc.
Aalborg University Hospital
University of Virginia
Pancreatic Cancer Research Team
NHS Greater Glasgow and Clyde